PATRICK DESIR: Open Payments
NPI 1700401650 · SAINT PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,835 in 108 payments from 15 companies in 2025. Trend: 2023 $1,176 · 2024 $1,360 · 2025 $1,835
Food & beverage: $1,835
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $333 |
| Supernus Pharmaceuticals, Inc. | 32 | $316 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $246 |
| Axsome Therapeutics, Inc. | 6 | $190 |
| Otsuka America Pharmaceutical, Inc. | 10 | $170 |
| Alkermes, Inc. | 7 | $136 |
| Janssen Pharmaceuticals, Inc | 5 | $105 |
| Vanda Pharmaceuticals Inc. | 4 | $92 |
| Neurocrine BioSciences, Inc. | 3 | $60 |
| Corium, LLC | 4 | $60 |
Products named: VRAYLAR, Qelbree, CAPLYTA, REXULTI, Auvelity, ARISTADA, SPRAVATO, INGREZZA.
Industry payments across FL — which companies pay providers there.
